Verification of the Efficacy and Safety of Qi-Replenishing Chinese Medicine in Treating Prediabetes: A Meta-Analysis and Literature Review
Table 1
PICOS criteria for inclusion and exclusion of literatures in this study.
Parameters
Inclusion criteria
Exclusion criteria
Patients
Patients with prediabetes
Patients with diabetes, or patients without prediabetes.
Intervention
Treatment using qi-replenishing Chinese medicine
Treatment without using qi-replenishing Chinese medicine
Comparison
Treatment using lifestyle modification (LM), or LM + metformin, or LM + placebo
Treatment without using LM
Outcome
Incidence of diabetes, or normalization of blood glucose (NBG), or fasting blood glucose (FBG), or 2 h postprandial blood glucose (2hPG), or HbA1c, or adverse event
Without using the indices of incidence of diabetes, NBG, FBG, 2hPG, HbA1c and adverse event
Study design
Randomized controlled trials (RCTs) and Jadad score ≥4